Fund shareholders of Revolution Medicines Inc
ISIN US76155X1000 · United States · LEI 549300JU3X0LBCQ65892
- Fund shareholders
- 420
- Of which ETFs
- 98 322 other funds
- Value held
- 5.1B $ 404.1M SEK · 677.8K €
- Share of capital
- 22.6 % of 214.3M shares on Jul 31, 2026
This issuer has other securities : REVOLUTION MEDICINES INC WTS 12/26 (US76155X1182)
420 funds hold this company. This table lists the 419 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 15,087 | 2.2M $ | 1.19 % | 0.01 % | as of Apr 30, 2026 ↗ |
| M Capital Appreciation Fund M FUND INC | 14,993 | 1.5M $ | 0.56 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Calamos Growth Fund CALAMOS INVESTMENT TRUST/IL | 14,962 | 2.2M $ | 0.13 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Core ETF Columbia ETF Trust I | 14,622 | 2.1M $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Focused Growth Fund LORD ABBETT SECURITIES TRUST | 14,414 | 2.1M $ | 1.28 % | 0.01 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Total Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 14,294 | 1.4M $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 14,125 | 1.4M $ | 0.37 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 14,012 | 1.4M $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Schwab 1000 Index ETF SCHWAB STRATEGIC TRUST | 13,948 | 1.4M $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Venerable Mid Cap Index Fund Venerable Variable Insurance Trust | 13,608 | 1.3M $ | 0.13 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Research Portfolio JANUS ASPEN SERIES | 13,465 | 1.3M $ | 0.20 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Wellington Small Cap Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 13,205 | 1.3M $ | 0.36 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Mid Cap Value Managed Volatility Portfolio EQ Advisors Trust | 13,140 | 1.3M $ | 0.09 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Value ETF iShares Trust | 13,077 | 1.9M $ | 0.29 % | 0.01 % | as of Apr 30, 2026 ↗ |
| JNL/Mellon U.S. Stock Market Index Fund JNL Series Trust | 12,957 | 1.3M $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 12,145 | 1.2M $ | 0.26 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 11,995 | 1.2M $ | 2.21 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Variable Portfolio - Partners Small Cap Growth Fund Columbia Funds Variable Series Trust II | 11,859 | 1.2M $ | 0.35 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Columbia Variable Portfolio - Small Company Growth Fund COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 11,686 | 1.1M $ | 0.53 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 11,375 | 1.2M $ | 0.14 % | 0.01 % | as of Feb 28, 2026 ↗ |
| AQR Large Cap Momentum Style Fund AQR Funds | 11,282 | 1.1M $ | 0.19 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity OTC K6 Portfolio Fidelity Securities Fund | 11,000 | 1.6M $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 10,990 | 1.6M $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 10,938 | 1.1M $ | 1.47 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Aristotle Growth Equity Fund Aristotle Fund Series Trust | 10,816 | 1.1M $ | 0.48 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/Large Cap Value Managed Volatility Portfolio EQ Advisors Trust | 10,384 | 1M $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Franklin Alternative Strategies Fund Franklin Alternative Strategies Funds | 9,813 | 1M $ | 0.19 % | 0.00 % | as of Feb 27, 2026 ↗ |
| MML Small Cap Growth Equity Fund MML SERIES INVESTMENT FUND | 9,714 | 944.7K $ | 0.71 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Growth Fund Penn Series Funds Inc | 9,346 | 908.9K $ | 1.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 9,327 | 1.3M $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ALGER HEALTH SCIENCES FUND ALGER FUNDS | 9,047 | 1.3M $ | 2.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 8,927 | 910.7K $ | 0.99 % | 0.00 % | as of Feb 28, 2026 ↗ |
| The Hartford Small Cap Growth Fund HARTFORD MUTUAL FUNDS II, INC | 8,545 | 1.2M $ | 0.40 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Storebrand Global All Countries Storebrand Asset Management AS | 8,540 | 7.9M SEK | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya RussellTM Mid Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 8,493 | 825.9K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 1000 Equal Weight ETF Invesco Exchange-Traded Fund Trust II | 8,301 | 846.9K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 8,171 | 1.2M $ | 0.44 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SEB USA Exposure SEB Funds AB | 8,084 | 7.5M SEK | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory RS Select Growth Fund Victory Portfolios | 7,810 | 759.5K $ | 1.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/RAFI Multi-Factor U.S. Equity Fund JNL Series Trust | 7,649 | 743.9K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series SMID Cap Growth Fund Penn Series Funds Inc | 7,626 | 741.6K $ | 1.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Calvert U.S. Mid Cap Core Responsible Index Fund Calvert Responsible Index Series, Inc. | 7,537 | 733K $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Size Factor ETF iShares Trust | 7,534 | 1.1M $ | 0.27 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ALGER MID CAP GROWTH FUND ALGER FUNDS | 7,488 | 1.1M $ | 0.39 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Large Cap Value Fund Bridge Builder Trust | 7,435 | 723.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Inspire 500 ETF Northern Lights Fund Trust IV | 7,392 | 754.1K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Penn Series Small Cap Value Fund Penn Series Funds Inc | 7,322 | 712.1K $ | 0.49 % | 0.00 % | as of Mar 31, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 7,190 | 1M $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Small Cap Stock Fund Victory Portfolios III | 7,076 | 1M $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Skandia Global Exponering Skandia Fonder AB | 7,000 | 6.5M SEK | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 6,619 | 643.7K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 6,612 | 643K $ | 0.62 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Large Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 6,497 | 662.8K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 6,455 | 627.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Disciplined Value Fund Columbia Funds Series Trust II | 6,436 | 927.6K $ | 0.48 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Putnam VT Global Health Care Fund Putnam Variable Trust | 6,300 | 612.7K $ | 0.43 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta U.S. 1000 Equity ETF Goldman Sachs ETF Trust II | 6,160 | 628.4K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 6,158 | 887.5K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Transformational Growth ETF Janus Detroit Street Trust | 6,070 | 874.8K $ | 2.41 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Brighthouse/Wellington Balanced Portfolio Brighthouse Funds Trust II | 5,913 | 575K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap Value Index Fund SCHWAB CAPITAL TRUST | 5,843 | 842.1K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Large Cap Value Index Portfolio EQ Advisors Trust | 5,531 | 537.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MML Mid Cap Growth Fund MML SERIES INVESTMENT FUND | 5,521 | 536.9K $ | 0.15 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PRAXIS SMALL CAP INDEX FUND Praxis Mutual Funds | 5,402 | 525.3K $ | 0.26 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Fund Trust for Professional Managers | 5,356 | 546.4K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Stock Selector Large Cap Value Fund Fidelity Devonshire Trust | 5,300 | 763.8K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Mid Cap Equity ETF American Century ETF Trust | 5,175 | 528K $ | 0.17 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Blended Mid Cap Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 5,059 | 492K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Large-Cap Value Index Portfolio PACIFIC SELECT FUND | 4,973 | 483.6K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT LARGE CAP INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 4,900 | 499.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| WCM Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST | 4,832 | 469.9K $ | 1.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 4,742 | 683.4K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 4,672 | 454.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 4,654 | 452.6K $ | 1.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Tactical Opportunities Fund BlackRock Funds | 4,604 | 663.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 4,546 | 655.2K $ | 2.38 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 4,532 | 440.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 4,503 | 437.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Health Care Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 4,495 | 437.1K $ | 0.29 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Mid Cap Value Portfolio JANUS ASPEN SERIES | 4,491 | 436.7K $ | 0.37 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Value Equity Index Fund GuideStone Funds | 4,464 | 434.1K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Institutional Small-Cap Equity Fund STATE STREET INSTITUTIONAL FUNDS | 4,357 | 423.7K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Alger Mid Cap Growth Portfolio ALGER PORTFOLIOS | 4,161 | 404.7K $ | 0.29 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Large Cap Value Fund BlackRock Large Cap Series Funds, Inc. | 4,039 | 412.1K $ | 0.05 % | 0.00 % | as of Feb 27, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 4,021 | 391K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series MC Portfolio Voya VARIABLE PORTFOLIOS INC | 3,908 | 380.1K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Mid-Cap Index Portfolio PACIFIC SELECT FUND | 3,898 | 379.1K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SPP Generation 70-tal Storebrand Asset Management AS | 3,870 | 3.6M SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 3,747 | 364.4K $ | 0.24 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 3,678 | 357.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/RAFI Fundamental U.S. Small Cap Fund JNL Series Trust | 3,646 | 354.6K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Large Cap Equity ETF American Century ETF Trust | 3,606 | 367.9K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| AST PGIM Aggressive Multi-Asset Portfolio Advanced Series Trust | 3,570 | 347.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL Russell 1000 Value Index Fund Allianz Variable Insurance Products Trust | 3,564 | 346.6K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 3,496 | 503.8K $ | 1.35 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Innovate Equity ETF Goldman Sachs ETF Trust | 3,453 | 352.3K $ | 0.17 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Calamos Timpani SMID Growth Fund CALAMOS INVESTMENT TRUST/IL | 3,405 | 490.7K $ | 1.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Global Opportunities Fund Columbia Funds Series Trust II | 3,397 | 489.6K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 3,336 | 324.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 3,316 | 322.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 6.85 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 6.29 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.13 % | as of Mar 31, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 3.22 % | as of Mar 31, 2026 ↗ |
| Pinnacle Focused Opportunities ETF Tidal Trust II | 3.15 % | as of Feb 28, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 2.98 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.86 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.82 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Transformational Growth ETF Janus Detroit Street Trust | 2.41 % | as of Apr 30, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 2.38 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 400 | +41 | 47,949,343 | -6.1 % |
| 2026Q1 | 359 | +41 | 51,041,234 | -8.6 % |
| 2025Q4 | 318 | -18 | 55,857,845 | -6.5 % |
| 2025Q3 | 336 | +10 | 59,732,762 | -7.8 % |
| 2025Q2 | 326 | +4 | 64,794,405 | +3.7 % |
| 2025Q1 | 322 | +9 | 62,505,392 | +5.6 % |
| 2024Q4 | 313 | +26 | 59,209,688 | +5.5 % |
| 2024Q3 | 287 | +20 | 56,129,869 | +4.9 % |
| 2024Q2 | 267 | +18 | 53,490,879 | +17.6 % |
| 2024Q1 | 249 | +26 | 45,498,077 | +12.7 % |
| 2023Q4 | 223 | 40,365,735 |
Institutional managers
503 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 13,604,796 | 1.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 11,212,706 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 9,766,496 | 949.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 9,555,357 | 929.3M $ | as of Mar 31, 2026 |
| FMR LLC | 8,464,314 | 823.2M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 7,601,087 | 739.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 6,655,703 | 647.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,027,819 | 586.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,475,611 | 532.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,402,662 | 428.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,386,791 | 426.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,338,142 | 323.9M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 3,292,525 | 320.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,232,213 | 314.3K $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,856,782 | 277.8M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 2,577,333 | 250.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,506,570 | 243.8M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 2,468,644 | 240.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,375,000 | 231M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,344,444 | 228M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,297,000 | 223.4M $ | as of Mar 31, 2026 |
| Darwin Global Management, Ltd. | 2,211,018 | 205M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,185,500 | 212.5M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,000,000 | 194.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,885,821 | 183.4M $ | as of Mar 31, 2026 |
Declared shareholders of Revolution Medicines Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.90 % | 9,766,496 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Revolution Medicines Inc
12 funds declare 12 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| NYLI MacKay Convertible Fund | 1 | 18.9M $ | as of Apr 30, 2026 |
| Calamos Growth & Income Fund | 1 | 12.3M $ | as of Apr 30, 2026 |
| Calamos Market Neutral Income Fund | 1 | 6M $ | as of Apr 30, 2026 |
| Calamos Convertible Fund | 1 | 5M $ | as of Apr 30, 2026 |
| Putnam Convertible Securities Fund | 1 | 4.6M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 3.3M $ | as of Apr 30, 2026 |
| Calamos Global Opportunities Fund | 1 | 1.6M $ | as of Apr 30, 2026 |
| Miller Market Neutral Income Fund | 1 | 753K $ | as of Apr 30, 2026 |
| First Trust SSI Strategic Convertible Securities ETF | 1 | 568.2K $ | as of Apr 30, 2026 |
| Calamos Global Convertible Fund | 1 | 402K $ | as of Apr 30, 2026 |
| Janus Henderson Income ETF | 1 | 344.5K $ | as of Apr 30, 2026 |
| Miller Convertible Total Return ETF | 1 | 55.8K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Revolution Medicines Inc". https://titelia.com/en/stocks/revolution-medicines-inc-US76155X1000